State-of-the-art cancer services coming to Billings Clinic Miles City
Many cancer patients in Miles City will soon have a state-of-the-art treatment option at Billings Clinic Miles City. By the end of 2021, Billings Clinic Miles City will introduce radiation therapy services using a mobile Halcyon linear accelerator, which provides dedicated radiation treatment for cancer patients.
“Having this state-of-the-art linear accelerator is an incredible resource for cancer patients in and around Miles City,” said Dr. Christopher Goulet, department chair of radiation oncology at Billings Clinic. “With the next closest similar treatment services a two-hour drive away, it will allow patients in this region to have dedicated radiation oncology services while they stay closer to home and their families.”
An expert, caring team of board-certified radiation oncologists, medical physicists, nurses, medical dosimetrists, radiation therapists and support staff will all work together to care for patients. There will be a full-time radiation therapist treating patients five days a week, with a radiation oncologist on site weekly and additional support will be available via telemedicine. The linear accelerator and radiation therapy treatment complement existing medical oncology and infusion therapy services already available at Billings Clinic Miles City.
The Halcyon linear accelerator helps to provided targeted, fast and high-quality radiation therapy treatment to cancer patients. It does this by directing a beam of high energy x-rays at a tumor to destroy cancer cells, while avoiding surrounding tissues. Site preparation at Billings Clinic Miles City is underway and the unit is expected to be onsite and available to patients beginning in mid-December.
The mobile unit will be provided through a partnership between Billings Clinic and Alliance Oncology.
Pictured below: Site work is underway at Billings Clinic Miles City to prepare for the arrival of a mobile linear accelerator unit, which will provide radiation treatment for cancer patients.